Smit, M J & COUGH-1 trial study group 2023, ' First-in-human use of a modular capsid virus-like vaccine platform : An open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2 ', The Lancet Microbe, vol. 4, no. 3, pp. e140-e148 . https://doi.org/10.1016/S2666-5247(22)00337-8 The Lancet Microbe, 4, 3, pp. e140-e148 The Lancet Microbe, 4, e140-e148
Clinical Infectious Diseases, 75, 1, pp. e938-e946 Clinical Infectious Diseases, 75(1), E938-E946. Oxford University Press Clinical Infectious Diseases, 75, e938-e946 Moorlag, S J C F M, Taks, E, ten Doesschate, T, van der Vaart, T W, Janssen, A B, Müller, L, Ostermann, P, Dijkstra, H, Lemmers, H, Simonetti, E, Mazur, M, Schaal, H, ter Heine, R, van de Veerdonk, F L, Bleeker-Rovers, C P, van Crevel, R, ten Oever, J, de Jonge, M I, Bonten, M J, van Werkhoven, C H & Netea, M G 2022, ' Efficacy of BCG Vaccination Against Respiratory Tract Infections in Older Adults During the Coronavirus Disease 2019 Pandemic ', Clinical Infectious Diseases, vol. 75, no. 1, pp. E938-E946 . https://doi.org/10.1093/cid/ciac182